Circulating haematopoietic stem cells and long-term outcomes of COVID-19.

Benedetta Maria BonoraMarella MarassiPaola FogarJenny ZuinRoberta CappellariSerena MarinelloAnna FerrariAnnamaria CattelanAngelo AvogaroDaniela BassoGian Paolo Fadini

Published in: European journal of clinical investigation (2023)

In a cohort of patients hospitalized for COVID-19, lower HSPC levels at the time of admission were independent predictors of 1-year mortality. However, COVID-19 severity, but not HSPC level, was significantly associated with the development of long-COVID symptoms.

Keyphrases

coronavirus disease
sars cov
stem cells
end stage renal disease
respiratory syndrome coronavirus
chronic kidney disease
emergency department
newly diagnosed
type diabetes
risk factors
cardiovascular disease
depressive symptoms
bone marrow
mesenchymal stem cells